pharma news

News

Now Iktos teams up with Pierre Fabre in oncology

As Servier announces its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has revealed an integrated collaboration with Iktos

News

$100 bill with missing puzzle pieces to be inserted

Parabilis scores $305m in bumper biofinancing week

Money has flooded into biotechs this week, with Parabilis raising $305m and five other start-ups closing nine-figure private rounds.

News

Spinning top in black and white, revolving

Report says MSD is in talks to buy Revolution Meds

MSD is rumoured to be in talks to buy Revolution Medicines and its KRAS inhibitor pipeline in a deal that could be worth up to $32 billion.

News

Iktos' Chemspeed robotics-powered chemistry platform

Servier signs €1bn-plus AI pact with Iktos

In its second AI-focused drug discovery deal in the space of a week, Servier has announced a €1bn partnership with France's Iktos.

News

Court blocks HHS' 340B rebate programme pilot

Hospitals that challenged a US pilot of a new rebate model for medicines provided to low-income people have won another legal victory.

News

Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer

Hengrui has achieved a milestone in oncology as retlirafusp alfa is approved in China, its first world market, for gastric cancer.

Now Iktos teams up with Pierre Fabre in oncology

Parabilis scores $305m in bumper biofinancing week

Report says MSD is in talks to buy Revolution Meds

Servier signs €1bn-plus AI pact with Iktos

Court blocks HHS' 340B rebate programme pilot

Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer

UK body raps Sanofi for disparaging Pfizer's RSV jab

How to meet your physicians where they are online

pharma news

Editor's Picks